| Computer hardware | 3 years | ||||
| Machinery and equipment | 2\u20135 years | ||||
| Automobiles | 5 years | ||||
| Leasehold improvements | Shorter of lease period or useful life | ||||
| Furniture and fixtures | 7 years |
| Computer hardware | 3 years | ||||
| Machinery and equipment | 2\u20135 years | ||||
| Automobiles | 5 years | ||||
| Leasehold improvements | Shorter of lease period or useful life | ||||
| Furniture and fixtures | 7 years |
(in thousands) | 2024 | 2023 | |||||||||
| Computer hardware | $ | 18,036\u00a0 | $ | 20,970\u00a0 | |||||||
Machinery and equipment(1) | 16,451\u00a0 | 14,825\u00a0 | |||||||||
| Leasehold improvements | 18,870\u00a0 | 20,422\u00a0 | |||||||||
| Furniture and fixtures | 4,705\u00a0 | 4,591\u00a0 | |||||||||
| Work in progress | 308\u00a0 | 338\u00a0 | |||||||||
| Total | 58,370\u00a0 | 61,146\u00a0 | |||||||||
| Less accumulated depreciation | (39,397) | (33,694) | |||||||||
| Property and equipment\u2014net | $ | 18,973\u00a0 | $ | 27,452\u00a0 |
| Level 1 | Unadjusted quoted prices in active markets for identical assets or liabilities | ||||
| Level 2 | Unadjusted quoted prices in active markets for similar assets or liabilities; or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; or inputs other than quoted prices that are observable for the asset or liability. | ||||
| Level 3 | Significant unobservable inputs for the asset or liability |
| Level 1 | Unadjusted quoted prices in active markets for identical assets or liabilities | ||||
| Level 2 | Unadjusted quoted prices in active markets for similar assets or liabilities; or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; or inputs other than quoted prices that are observable for the asset or liability. | ||||
| Level 3 | Significant unobservable inputs for the asset or liability |
(in thousands) | 2024 | 2023 | |||||||||
| Computer hardware | $ | 18,036\u00a0 | $ | 20,970\u00a0 | |||||||
Machinery and equipment(1) | 16,451\u00a0 | 14,825\u00a0 | |||||||||
| Leasehold improvements | 18,870\u00a0 | 20,422\u00a0 | |||||||||
| Furniture and fixtures | 4,705\u00a0 | 4,591\u00a0 | |||||||||
| Work in progress | 308\u00a0 | 338\u00a0 | |||||||||
| Total | 58,370\u00a0 | 61,146\u00a0 | |||||||||
| Less accumulated depreciation | (39,397) | (33,694) | |||||||||
| Property and equipment\u2014net | $ | 18,973\u00a0 | $ | 27,452\u00a0 |
(in thousands) | 2024 | 2023 | |||||||||
| Software | $ | 28,287\u00a0 | $ | 35,945\u00a0 | |||||||
| Work in progress | 78\u00a0 | 143\u00a0 | |||||||||
| Total | 28,365\u00a0 | 36,088\u00a0 | |||||||||
| Less accumulated amortization | (14,387) | (21,348) | |||||||||
| Software\u2014net | $ | 13,978\u00a0 | $ | 14,740\u00a0 |
(in thousands) | 2024 | 2023 | |||||||||
| Software | $ | 28,287\u00a0 | $ | 35,945\u00a0 | |||||||
| Work in progress | 78\u00a0 | 143\u00a0 | |||||||||
| Total | 28,365\u00a0 | 36,088\u00a0 | |||||||||
| Less accumulated amortization | (14,387) | (21,348) | |||||||||
| Software\u2014net | $ | 13,978\u00a0 | $ | 14,740\u00a0 |
| (in thousands) | Balance Sheet Classification | 2024 | 2023 | ||||||||||||||
| Assets | |||||||||||||||||
| Operating leases | Operating lease right-of-use assets | $ | 23,437\u00a0 | $ | 23,563\u00a0 | ||||||||||||
| Finance leases | 191\u00a0 | 221\u00a0 | |||||||||||||||
| Total lease right-of-use assets | $ | 23,628\u00a0 | $ | 23,784\u00a0 | |||||||||||||
| Liabilities | |||||||||||||||||
| Current | |||||||||||||||||
| Operating leases | Operating lease liabilities\u2013current | $ | 4,709\u00a0 | $ | 5,175\u00a0 | ||||||||||||
| Finance leases | 130\u00a0 | 127\u00a0 | |||||||||||||||
| Non-current | |||||||||||||||||
| Operating leases | Operating lease liabilities | 25,685\u00a0 | 27,892\u00a0 | ||||||||||||||
| Finance leases | 66\u00a0 | 98\u00a0 | |||||||||||||||
| Total lease liabilities | $ | 30,590\u00a0 | $ | 33,292\u00a0 |
| Year Ended June 30, | Year Ended June 30, | ||||||||||
| (in thousands) | 2024 | 2023 | |||||||||
Finance lease costs(1) | $ | 168\u00a0 | $ | 173\u00a0 | |||||||
Operating lease costs(2) | 5,649\u00a0 | 7,874\u00a0 | |||||||||
| Short-term lease costs | 243\u00a0 | 201\u00a0 | |||||||||
Variable lease costs(3) | 613\u00a0 | 599\u00a0 | |||||||||
| Sublease income | (2,294) | (2,190) | |||||||||
| Total net lease costs | $ | 4,379\u00a0 | $ | 6,657\u00a0 |
| Year Ended June 30, | Year Ended June 30, | ||||||||||||||||||||||||||||||||||
| 2024 | 2023 | ||||||||||||||||||||||||||||||||||
| (in thousands) | Operating leases | Finance leases | Total | Operating leases | Finance leases | Total | |||||||||||||||||||||||||||||
| Cash paid for amounts included in measurement of liabilities: | |||||||||||||||||||||||||||||||||||
| Operating cash flows from leases | $ | 8,197\u00a0 | $ | 18\u00a0 | $ | 8,215\u00a0 | $ | 9,388\u00a0 | $ | 17\u00a0 | $ | 9,405\u00a0 | |||||||||||||||||||||||
| Financing cash flows from leases | \u2014 | 149\u00a0 | 149\u00a0 | \u2014\u00a0 | 156\u00a0 | 156\u00a0 | |||||||||||||||||||||||||||||
| Right-of-use assets obtained in exchange for new lease liabilities | $ | 1,307\u00a0 | $ | 120\u00a0 | $ | 1,427\u00a0 | $ | (347) | $ | 116\u00a0 | $ | (231) |
| Year Ended June 30, | Year Ended June 30, | ||||||||||||||||||||||
| 2024 | 2023 | ||||||||||||||||||||||
| Operating leases | Finance leases | Operating leases | Finance leases | ||||||||||||||||||||
| Weighted-average remaining lease term (in years) | 5.92 | 1.84 | 6.11 | 2.55 | |||||||||||||||||||
| Weighted-average discount rate | 11.80\u00a0 | % | 9.96\u00a0 | % | 10.33\u00a0 | % | 10.81\u00a0 | % |
| (in thousands) | Operating leases | Finance leases | Total | |||||||||||||||||
| 2025 | $ | 7,911\u00a0 | $ | 140\u00a0 | $ | 8,051\u00a0 | ||||||||||||||
| 2026 | 7,377\u00a0 | 38\u00a0 | 7,415\u00a0 | |||||||||||||||||
| 2027 | 6,536\u00a0 | 32\u00a0 | 6,568\u00a0 | |||||||||||||||||
| 2028 | 6,049\u00a0 | \u2014\u00a0 | 6,049\u00a0 | |||||||||||||||||
| 2029 | 6,127\u00a0 | \u2014\u00a0 | 6,127\u00a0 | |||||||||||||||||
| Thereafter | 8,826\u00a0 | \u2014\u00a0 | 8,826\u00a0 | |||||||||||||||||
| \u00a0\u00a0\u00a0\u00a0\u00a0Total undiscounted lease payments | 42,826\u00a0 | 210\u00a0 | 43,036\u00a0 | |||||||||||||||||
| Less: interest | 12,432\u00a0 | 14\u00a0 | 12,446\u00a0 | |||||||||||||||||
| \u00a0\u00a0\u00a0\u00a0\u00a0Present value of lease liabilities | $ | 30,394\u00a0 | $ | 196\u00a0 | $ | 30,590\u00a0 |
| (in thousands) | Total | |||||||
| 2025 | $ | 2,548\u00a0 | ||||||
| 2026 | 2,587\u00a0 | |||||||
| 2027 | 2,180\u00a0 | |||||||
| 2028 | 1,931\u00a0 | |||||||
| 2029 | 1,931\u00a0 | |||||||
| Thereafter | 161\u00a0 | |||||||
| Total sublease income | $ | 11,338\u00a0 |
| (in thousands) | Balance Sheet Classification | 2024 | 2023 | ||||||||||||||
| Assets | |||||||||||||||||
| Operating leases | Operating lease right-of-use assets | $ | 23,437\u00a0 | $ | 23,563\u00a0 | ||||||||||||
| Finance leases | 191\u00a0 | 221\u00a0 | |||||||||||||||
| Total lease right-of-use assets | $ | 23,628\u00a0 | $ | 23,784\u00a0 | |||||||||||||
| Liabilities | |||||||||||||||||
| Current | |||||||||||||||||
| Operating leases | Operating lease liabilities\u2013current | $ | 4,709\u00a0 | $ | 5,175\u00a0 | ||||||||||||
| Finance leases | 130\u00a0 | 127\u00a0 | |||||||||||||||
| Non-current | |||||||||||||||||
| Operating leases | Operating lease liabilities | 25,685\u00a0 | 27,892\u00a0 | ||||||||||||||
| Finance leases | 66\u00a0 | 98\u00a0 | |||||||||||||||
| Total lease liabilities | $ | 30,590\u00a0 | $ | 33,292\u00a0 |
| Year Ended June 30, | Year Ended June 30, | ||||||||||
| (in thousands) | 2024 | 2023 | |||||||||
Finance lease costs(1) | $ | 168\u00a0 | $ | 173\u00a0 | |||||||
Operating lease costs(2) | 5,649\u00a0 | 7,874\u00a0 | |||||||||
| Short-term lease costs | 243\u00a0 | 201\u00a0 | |||||||||
Variable lease costs(3) | 613\u00a0 | 599\u00a0 | |||||||||
| Sublease income | (2,294) | (2,190) | |||||||||
| Total net lease costs | $ | 4,379\u00a0 | $ | 6,657\u00a0 |
| Year Ended June 30, | Year Ended June 30, | ||||||||||||||||||||||||||||||||||
| 2024 | 2023 | ||||||||||||||||||||||||||||||||||
| (in thousands) | Operating leases | Finance leases | Total | Operating leases | Finance leases | Total | |||||||||||||||||||||||||||||
| Cash paid for amounts included in measurement of liabilities: | |||||||||||||||||||||||||||||||||||
| Operating cash flows from leases | $ | 8,197\u00a0 | $ | 18\u00a0 | $ | 8,215\u00a0 | $ | 9,388\u00a0 | $ | 17\u00a0 | $ | 9,405\u00a0 | |||||||||||||||||||||||
| Financing cash flows from leases | \u2014 | 149\u00a0 | 149\u00a0 | \u2014\u00a0 | 156\u00a0 | 156\u00a0 | |||||||||||||||||||||||||||||
| Right-of-use assets obtained in exchange for new lease liabilities | $ | 1,307\u00a0 | $ | 120\u00a0 | $ | 1,427\u00a0 | $ | (347) | $ | 116\u00a0 | $ | (231) |
| Year Ended June 30, | Year Ended June 30, | ||||||||||||||||||||||
| 2024 | 2023 | ||||||||||||||||||||||
| Operating leases | Finance leases | Operating leases | Finance leases | ||||||||||||||||||||
| Weighted-average remaining lease term (in years) | 5.92 | 1.84 | 6.11 | 2.55 | |||||||||||||||||||
| Weighted-average discount rate | 11.80\u00a0 | % | 9.96\u00a0 | % | 10.33\u00a0 | % | 10.81\u00a0 | % |
| (in thousands) | Operating leases | Finance leases | Total | |||||||||||||||||
| 2025 | $ | 7,911\u00a0 | $ | 140\u00a0 | $ | 8,051\u00a0 | ||||||||||||||
| 2026 | 7,377\u00a0 | 38\u00a0 | 7,415\u00a0 | |||||||||||||||||
| 2027 | 6,536\u00a0 | 32\u00a0 | 6,568\u00a0 | |||||||||||||||||
| 2028 | 6,049\u00a0 | \u2014\u00a0 | 6,049\u00a0 | |||||||||||||||||
| 2029 | 6,127\u00a0 | \u2014\u00a0 | 6,127\u00a0 | |||||||||||||||||
| Thereafter | 8,826\u00a0 | \u2014\u00a0 | 8,826\u00a0 | |||||||||||||||||
| \u00a0\u00a0\u00a0\u00a0\u00a0Total undiscounted lease payments | 42,826\u00a0 | 210\u00a0 | 43,036\u00a0 | |||||||||||||||||
| Less: interest | 12,432\u00a0 | 14\u00a0 | 12,446\u00a0 | |||||||||||||||||
| \u00a0\u00a0\u00a0\u00a0\u00a0Present value of lease liabilities | $ | 30,394\u00a0 | $ | 196\u00a0 | $ | 30,590\u00a0 |
| (in thousands) | Total | |||||||
| 2025 | $ | 2,548\u00a0 | ||||||
| 2026 | 2,587\u00a0 | |||||||
| 2027 | 2,180\u00a0 | |||||||
| 2028 | 1,931\u00a0 | |||||||
| 2029 | 1,931\u00a0 | |||||||
| Thereafter | 161\u00a0 | |||||||
| Total sublease income | $ | 11,338\u00a0 |
| (in thousands) | Balance Sheet Classification | 2024 | 2023 | ||||||||||||||
| Assets | |||||||||||||||||
| Operating leases | Operating lease right-of-use assets | $ | 23,437\u00a0 | $ | 23,563\u00a0 | ||||||||||||
| Finance leases | 191\u00a0 | 221\u00a0 | |||||||||||||||
| Total lease right-of-use assets | $ | 23,628\u00a0 | $ | 23,784\u00a0 | |||||||||||||
| Liabilities | |||||||||||||||||
| Current | |||||||||||||||||
| Operating leases | Operating lease liabilities\u2013current | $ | 4,709\u00a0 | $ | 5,175\u00a0 | ||||||||||||
| Finance leases | 130\u00a0 | 127\u00a0 | |||||||||||||||
| Non-current | |||||||||||||||||
| Operating leases | Operating lease liabilities | 25,685\u00a0 | 27,892\u00a0 | ||||||||||||||
| Finance leases | 66\u00a0 | 98\u00a0 | |||||||||||||||
| Total lease liabilities | $ | 30,590\u00a0 | $ | 33,292\u00a0 |
| Year Ended June 30, | Year Ended June 30, | ||||||||||
| (in thousands) | 2024 | 2023 | |||||||||
Finance lease costs(1) | $ | 168\u00a0 | $ | 173\u00a0 | |||||||
Operating lease costs(2) | 5,649\u00a0 | 7,874\u00a0 | |||||||||
| Short-term lease costs | 243\u00a0 | 201\u00a0 | |||||||||
Variable lease costs(3) | 613\u00a0 | 599\u00a0 | |||||||||
| Sublease income | (2,294) | (2,190) | |||||||||
| Total net lease costs | $ | 4,379\u00a0 | $ | 6,657\u00a0 |
| Year Ended June 30, | Year Ended June 30, | ||||||||||||||||||||||||||||||||||
| 2024 | 2023 | ||||||||||||||||||||||||||||||||||
| (in thousands) | Operating leases | Finance leases | Total | Operating leases | Finance leases | Total | |||||||||||||||||||||||||||||
| Cash paid for amounts included in measurement of liabilities: | |||||||||||||||||||||||||||||||||||
| Operating cash flows from leases | $ | 8,197\u00a0 | $ | 18\u00a0 | $ | 8,215\u00a0 | $ | 9,388\u00a0 | $ | 17\u00a0 | $ | 9,405\u00a0 | |||||||||||||||||||||||
| Financing cash flows from leases | \u2014 | 149\u00a0 | 149\u00a0 | \u2014\u00a0 | 156\u00a0 | 156\u00a0 | |||||||||||||||||||||||||||||
| Right-of-use assets obtained in exchange for new lease liabilities | $ | 1,307\u00a0 | $ | 120\u00a0 | $ | 1,427\u00a0 | $ | (347) | $ | 116\u00a0 | $ | (231) |
| Year Ended June 30, | Year Ended June 30, | ||||||||||||||||||||||
| 2024 | 2023 | ||||||||||||||||||||||
| Operating leases | Finance leases | Operating leases | Finance leases | ||||||||||||||||||||
| Weighted-average remaining lease term (in years) | 5.92 | 1.84 | 6.11 | 2.55 | |||||||||||||||||||
| Weighted-average discount rate | 11.80\u00a0 | % | 9.96\u00a0 | % | 10.33\u00a0 | % | 10.81\u00a0 | % |
| (in thousands) | Operating leases | Finance leases | Total | |||||||||||||||||
| 2025 | $ | 7,911\u00a0 | $ | 140\u00a0 | $ | 8,051\u00a0 | ||||||||||||||
| 2026 | 7,377\u00a0 | 38\u00a0 | 7,415\u00a0 | |||||||||||||||||
| 2027 | 6,536\u00a0 | 32\u00a0 | 6,568\u00a0 | |||||||||||||||||
| 2028 | 6,049\u00a0 | \u2014\u00a0 | 6,049\u00a0 | |||||||||||||||||
| 2029 | 6,127\u00a0 | \u2014\u00a0 | 6,127\u00a0 | |||||||||||||||||
| Thereafter | 8,826\u00a0 | \u2014\u00a0 | 8,826\u00a0 | |||||||||||||||||
| \u00a0\u00a0\u00a0\u00a0\u00a0Total undiscounted lease payments | 42,826\u00a0 | 210\u00a0 | 43,036\u00a0 | |||||||||||||||||
| Less: interest | 12,432\u00a0 | 14\u00a0 | 12,446\u00a0 | |||||||||||||||||
| \u00a0\u00a0\u00a0\u00a0\u00a0Present value of lease liabilities | $ | 30,394\u00a0 | $ | 196\u00a0 | $ | 30,590\u00a0 |
| (in thousands) | Operating leases | Finance leases | Total | |||||||||||||||||
| 2025 | $ | 7,911\u00a0 | $ | 140\u00a0 | $ | 8,051\u00a0 | ||||||||||||||
| 2026 | 7,377\u00a0 | 38\u00a0 | 7,415\u00a0 | |||||||||||||||||
| 2027 | 6,536\u00a0 | 32\u00a0 | 6,568\u00a0 | |||||||||||||||||
| 2028 | 6,049\u00a0 | \u2014\u00a0 | 6,049\u00a0 | |||||||||||||||||
| 2029 | 6,127\u00a0 | \u2014\u00a0 | 6,127\u00a0 | |||||||||||||||||
| Thereafter | 8,826\u00a0 | \u2014\u00a0 | 8,826\u00a0 | |||||||||||||||||
| \u00a0\u00a0\u00a0\u00a0\u00a0Total undiscounted lease payments | 42,826\u00a0 | 210\u00a0 | 43,036\u00a0 | |||||||||||||||||
| Less: interest | 12,432\u00a0 | 14\u00a0 | 12,446\u00a0 | |||||||||||||||||
| \u00a0\u00a0\u00a0\u00a0\u00a0Present value of lease liabilities | $ | 30,394\u00a0 | $ | 196\u00a0 | $ | 30,590\u00a0 |
| (in thousands) | Total | |||||||
| 2025 | $ | 2,548\u00a0 | ||||||
| 2026 | 2,587\u00a0 | |||||||
| 2027 | 2,180\u00a0 | |||||||
| 2028 | 1,931\u00a0 | |||||||
| 2029 | 1,931\u00a0 | |||||||
| Thereafter | 161\u00a0 | |||||||
| Total sublease income | $ | 11,338\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
| Cash | $ | 42,383\u00a0 | $ | 51,231\u00a0 | |||||||
| Money market funds | 307\u00a0 | 31,925\u00a0 | |||||||||
| Total cash and cash equivalents | $ | 42,690\u00a0 | $ | 83,156\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
Prepaid expenses(1) | $ | 5,555\u00a0 | $ | 7,057\u00a0 | |||||||
| Unrealized gain on interest rate swap contract | 5,027\u00a0 | \u2014\u00a0 | |||||||||
Inventory(2) | 8,758\u00a0 | 5,567\u00a0 | |||||||||
Other receivables(3) | 987\u00a0 | 1,731\u00a0 | |||||||||
| Total other current assets | $ | 20,327\u00a0 | $ | 14,355\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
Commission advances(1) | $ | 4,653\u00a0 | $ | 1,142\u00a0 | |||||||
| Financing lease liabilities-short term | 130\u00a0 | 127\u00a0 | |||||||||
Other(2) | 90 | 703 | |||||||||
| Total other current liabilities | $ | 4,873\u00a0 | $ | 1,972\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
| Financing lease liabilities-long term | $ | 66\u00a0 | $ | 98\u00a0 | |||||||
| Third-party commission liabilities | 788\u00a0 | 1,779\u00a0 | |||||||||
Other(1) | 1,023\u00a0 | 1,049\u00a0 | |||||||||
| Total other liabilities | $ | 1,877\u00a0 | $ | 2,926\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
| Cash | $ | 42,383\u00a0 | $ | 51,231\u00a0 | |||||||
| Money market funds | 307\u00a0 | 31,925\u00a0 | |||||||||
| Total cash and cash equivalents | $ | 42,690\u00a0 | $ | 83,156\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
Prepaid expenses(1) | $ | 5,555\u00a0 | $ | 7,057\u00a0 | |||||||
| Unrealized gain on interest rate swap contract | 5,027\u00a0 | \u2014\u00a0 | |||||||||
Inventory(2) | 8,758\u00a0 | 5,567\u00a0 | |||||||||
Other receivables(3) | 987\u00a0 | 1,731\u00a0 | |||||||||
| Total other current assets | $ | 20,327\u00a0 | $ | 14,355\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
Commission advances(1) | $ | 4,653\u00a0 | $ | 1,142\u00a0 | |||||||
| Financing lease liabilities-short term | 130\u00a0 | 127\u00a0 | |||||||||
Other(2) | 90 | 703 | |||||||||
| Total other current liabilities | $ | 4,873\u00a0 | $ | 1,972\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
| Financing lease liabilities-long term | $ | 66\u00a0 | $ | 98\u00a0 | |||||||
| Third-party commission liabilities | 788\u00a0 | 1,779\u00a0 | |||||||||
Other(1) | 1,023\u00a0 | 1,049\u00a0 | |||||||||
| Total other liabilities | $ | 1,877\u00a0 | $ | 2,926\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
| Financing lease liabilities-long term | $ | 66\u00a0 | $ | 98\u00a0 | |||||||
| Third-party commission liabilities | 788\u00a0 | 1,779\u00a0 | |||||||||
Other(1) | 1,023\u00a0 | 1,049\u00a0 | |||||||||
| Total other liabilities | $ | 1,877\u00a0 | $ | 2,926\u00a0 |
| 2024 | 2023 | |||||||||||||||||||||||||||||||||||||||||||
| Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Impairment Charges | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||||||||||||||||||||||
| Customer relationships | $ | 17,492\u00a0 | $ | (10,936) | $ | 6,556\u00a0 | $ | 17,492\u00a0 | $ | \u2014\u00a0 | $ | (8,617) | $ | 8,875\u00a0 | ||||||||||||||||||||||||||||||
| Trade name | 2,680\u00a0 | (2,233) | 447\u00a0 | 2,680\u00a0 | \u2014\u00a0 | (1,697) | 983\u00a0 | |||||||||||||||||||||||||||||||||||||
| Proprietary software | 4,342\u00a0 | (1,189) | 3,153\u00a0 | 1,042\u00a0 | \u2014\u00a0 | (758) | 284\u00a0 | |||||||||||||||||||||||||||||||||||||
| Non-compete agreements | 100\u00a0 | (62) | 38\u00a0 | 1,292\u00a0 | (533) | (701) | 58\u00a0 | |||||||||||||||||||||||||||||||||||||
| Vendor relationships | \u2014\u00a0 | \u2014\u00a0 | \u2014\u00a0 | 20,400\u00a0 | (15,111) | (5,289) | \u2014\u00a0 | |||||||||||||||||||||||||||||||||||||
| Total intangible assets | $ | 24,614\u00a0 | $ | (14,420) | $ | 10,194\u00a0 | $ | 42,906\u00a0 | $ | (15,644) | $ | (17,062) | $ | 10,200\u00a0 |
| Trade Name | Proprietary Software | Non-compete agreements | Customer relationships | Total | |||||||||||||||||||||||||
| 2025 | $ | 447\u00a0 | $ | 1,228\u00a0 | $ | 20\u00a0 | $ | 2,316\u00a0 | $ | 4,011\u00a0 | |||||||||||||||||||
| 2026 | \u2014\u00a0 | 1,100\u00a0 | 18\u00a0 | 2,313\u00a0 | 3,431\u00a0 | ||||||||||||||||||||||||
| 2027 | \u2014\u00a0 | 825\u00a0 | \u2014\u00a0 | 1,927\u00a0 | 2,752\u00a0 | ||||||||||||||||||||||||
| Total | $ | 447\u00a0 | $ | 3,153\u00a0 | $ | 38\u00a0 | $ | 6,556\u00a0 | $ | 10,194\u00a0 |
| 2024 | 2023 | |||||||||||||||||||||||||||||||||||||||||||
| Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Impairment Charges | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||||||||||||||||||||||
| Customer relationships | $ | 17,492\u00a0 | $ | (10,936) | $ | 6,556\u00a0 | $ | 17,492\u00a0 | $ | \u2014\u00a0 | $ | (8,617) | $ | 8,875\u00a0 | ||||||||||||||||||||||||||||||
| Trade name | 2,680\u00a0 | (2,233) | 447\u00a0 | 2,680\u00a0 | \u2014\u00a0 | (1,697) | 983\u00a0 | |||||||||||||||||||||||||||||||||||||
| Proprietary software | 4,342\u00a0 | (1,189) | 3,153\u00a0 | 1,042\u00a0 | \u2014\u00a0 | (758) | 284\u00a0 | |||||||||||||||||||||||||||||||||||||
| Non-compete agreements | 100\u00a0 | (62) | 38\u00a0 | 1,292\u00a0 | (533) | (701) | 58\u00a0 | |||||||||||||||||||||||||||||||||||||
| Vendor relationships | \u2014\u00a0 | \u2014\u00a0 | \u2014\u00a0 | 20,400\u00a0 | (15,111) | (5,289) | \u2014\u00a0 | |||||||||||||||||||||||||||||||||||||
| Total intangible assets | $ | 24,614\u00a0 | $ | (14,420) | $ | 10,194\u00a0 | $ | 42,906\u00a0 | $ | (15,644) | $ | (17,062) | $ | 10,200\u00a0 |
| Trade Name | Proprietary Software | Non-compete agreements | Customer relationships | Total | |||||||||||||||||||||||||
| 2025 | $ | 447\u00a0 | $ | 1,228\u00a0 | $ | 20\u00a0 | $ | 2,316\u00a0 | $ | 4,011\u00a0 | |||||||||||||||||||
| 2026 | \u2014\u00a0 | 1,100\u00a0 | 18\u00a0 | 2,313\u00a0 | 3,431\u00a0 | ||||||||||||||||||||||||
| 2027 | \u2014\u00a0 | 825\u00a0 | \u2014\u00a0 | 1,927\u00a0 | 2,752\u00a0 | ||||||||||||||||||||||||
| Total | $ | 447\u00a0 | $ | 3,153\u00a0 | $ | 38\u00a0 | $ | 6,556\u00a0 | $ | 10,194\u00a0 |
| (in thousands) | 2024 | 2023 | ||||||||||||||||||||||||
| Derivatives Designated as Hedging Instruments | Balance Sheet Location | Fair Value | Balance Sheet Location | Fair Value | ||||||||||||||||||||||
| Cash flow hedge | Other current assets | $ | 5,027\u00a0 | Other assets | $ | 17,861\u00a0 |
| (in thousands) | 2024 | 2023 | ||||||||||||
| Unrealized gain, before taxes | $ | 1,558\u00a0 | $ | 12,072\u00a0 | ||||||||||
| Income tax expense | (344) | (3,098) | ||||||||||||
| Unrealized gain, net of taxes | $ | 1,214\u00a0 | $ | 8,974\u00a0 |
| (in thousands) | 2024 | 2023 | ||||||||||||
Interest expense, net | $ | (14,392) | $ | (9,431) | ||||||||||
Income tax benefit | 3,611\u00a0 | 2,420\u00a0 | ||||||||||||
| Net reclassification into earnings | $ | (10,781) | $ | (7,011) |
| (in thousands) | Derivative Instruments | |||||||
Balance at June\u00a030, 2023 | $ | 13,679\u00a0 | ||||||
Unrealized gains, net of related tax expense of $(0.3)\u00a0million | 1,214\u00a0 | |||||||
Amount reclassified into earnings, net of related taxes of $3.6\u00a0million | (10,781) | |||||||
Balance at June\u00a030, 2024 | $ | 4,112\u00a0 |
| (in thousands) | 2024 | 2023 | ||||||||||||||||||||||||
| Derivatives Designated as Hedging Instruments | Balance Sheet Location | Fair Value | Balance Sheet Location | Fair Value | ||||||||||||||||||||||
| Cash flow hedge | Other current assets | $ | 5,027\u00a0 | Other assets | $ | 17,861\u00a0 |
| (in thousands) | 2024 | 2023 | ||||||||||||
| Unrealized gain, before taxes | $ | 1,558\u00a0 | $ | 12,072\u00a0 | ||||||||||
| Income tax expense | (344) | (3,098) | ||||||||||||
| Unrealized gain, net of taxes | $ | 1,214\u00a0 | $ | 8,974\u00a0 |
| (in thousands) | 2024 | 2023 | ||||||||||||
Interest expense, net | $ | (14,392) | $ | (9,431) | ||||||||||
Income tax benefit | 3,611\u00a0 | 2,420\u00a0 | ||||||||||||
| Net reclassification into earnings | $ | (10,781) | $ | (7,011) |
| (in thousands) | Derivative Instruments | |||||||
Balance at June\u00a030, 2023 | $ | 13,679\u00a0 | ||||||
Unrealized gains, net of related tax expense of $(0.3)\u00a0million | 1,214\u00a0 | |||||||
Amount reclassified into earnings, net of related taxes of $3.6\u00a0million | (10,781) | |||||||
Balance at June\u00a030, 2024 | $ | 4,112\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
Term Loans (effective interest rate 13.3%) | $ | 688,203\u00a0 | $ | 707,509\u00a0 | |||||||
| Unamortized debt issuance costs and debt discount | (4,869) | (9,001) | |||||||||
| Total debt | 683,334\u00a0 | 698,508\u00a0 | |||||||||
| Less current portion of long-term debt: | (45,854) | (33,883) | |||||||||
| Long-term debt | $ | 637,480\u00a0 | $ | 664,625\u00a0 |
| (in thousands) | 2024 | 2023 | |||||||||
Term Loans (effective interest rate 13.3%) | $ | 688,203\u00a0 | $ | 707,509\u00a0 | |||||||
| Unamortized debt issuance costs and debt discount | (4,869) | (9,001) | |||||||||
| Total debt | 683,334\u00a0 | 698,508\u00a0 | |||||||||
| Less current portion of long-term debt: | (45,854) | (33,883) | |||||||||
| Long-term debt | $ | 637,480\u00a0 | $ | 664,625\u00a0 |
| ESPP | 159\u00a0 | |||||||
| Stock awards outstanding under 2020 Plan | 17,940,564\u00a0 | |||||||
| Stock awards available for grant under 2020 Plan | 4,030,428\u00a0 | |||||||
| Options outstanding under 2003 Plan | 515,692\u00a0 | |||||||
| Total | 22,486,843\u00a0 |
| Year Ended June 30, | ||||||||||||||||||||
| (in thousands) | 2024 | 2023 | 2022 | |||||||||||||||||
| Share-based compensation related to: | ||||||||||||||||||||
| Equity classified stock options | $ | 2,733\u00a0 | $ | 3,249\u00a0 | $ | 3,145\u00a0 | ||||||||||||||
| Equity classified RSU's | 7,701\u00a0 | 5,958\u00a0 | 3,948\u00a0 | |||||||||||||||||
| Equity classified PSU's | 33\u00a0 | 100\u00a0 | (578) | |||||||||||||||||
| Equity classified PVU's | 3,349\u00a0 | 1,876\u00a0 | \u2014\u00a0 | |||||||||||||||||
| Total | $ | 13,816\u00a0 | $ | 11,183\u00a0 | $ | 6,515\u00a0 |
| Year Ended June 30, | |||||||||||
| 2022 | |||||||||||
Volatility | 36.0% | ||||||||||
Risk-free interest rate | 1.4% | ||||||||||
Dividend yield | \u2014% | ||||||||||
Assumed forfeitures | \u2014% | ||||||||||
Expected term (in years) | 6.25 | ||||||||||
Weighted-average fair value (per share) | $3.36 |
| Number of Options | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Term (in Years) | Aggregate Intrinsic Value (in Thousands) | |||||||||||
Outstanding\u2014June\u00a030, 2023 | 3,847,339\u00a0 | $ | 11.56\u00a0 | |||||||||||
| Options granted | \u2014\u00a0 | \u2014\u00a0 | ||||||||||||
| Options exercised | (46,769) | 1.74\u00a0 | ||||||||||||
| Options forfeited/expired/cancelled | (122,606) | 7.99\u00a0 | ||||||||||||
Outstanding\u2014June\u00a030, 2024 | 3,677,964\u00a0 | $ | 11.81\u00a0 | 6.40 | $ | 744\u00a0 | ||||||||
Vested and exercisable\u2014June\u00a030, 2024 | 2,492,868\u00a0 | $ | 11.97\u00a0 | 6.00 | $ | 630\u00a0 |
| Number of Restricted Stock Units | Weighted-Average Grant Date Fair Value | ||||||||||
Unvested as of June\u00a030, 2023 | 4,911,613\u00a0 | $ | 2.57\u00a0 | ||||||||
| Granted | 6,578,688\u00a0 | 1.49\u00a0 | |||||||||
| Vested | (2,664,436) | 2.06\u00a0 | |||||||||
| Forfeited | (384,697) | 2.12\u00a0 | |||||||||
Unvested as of June\u00a030, 2024 | 8,441,168\u00a0 | $ | 1.91\u00a0 |
| Number of Performance Stock Units | Weighted-Average Grant Date Fair Value | ||||||||||
Unvested as of June\u00a030, 2023 | 13,365\u00a0 | $ | 17.96\u00a0 | ||||||||
| Granted | \u2014\u00a0 | \u2014\u00a0 | |||||||||
| Vested | (14,477) | 17.95\u00a0 | |||||||||
| Forfeited | \u2014\u00a0 | \u2014\u00a0 | |||||||||
Performance adjustment(1) | 1,112\u00a0 | \u2014\u00a0 | |||||||||
Unvested as of June\u00a030, 2024 | \u2014\u00a0 | $ | \u2014\u00a0 |
| Number of Shares per Tranche | Grant Date Fair Value (per Share) | Stock Price Hurdle (per Share) | Performance Period | Requisite Service Period | ||||||||||||||||||||||||||||
| Tranche 1 | 559,202\u00a0 | $ | 1.85\u00a0 | $ | 2.50\u00a0 | August 1, 2023 - August 1, 2028 | 1 year - 3 years | |||||||||||||||||||||||||
| Tranche 2 | 559,175\u00a0 | $ | 1.69\u00a0 | $ | 5.00\u00a0 | August 1, 2023 - August 1, 2028 | 1.41 years - 3 years | |||||||||||||||||||||||||
| Tranche 3 | 559,213\u00a0 | $ | 1.55\u00a0 | $ | 7.50\u00a0 | August 1, 2023 - August 1, 2028 | 1.96 years - 3 years | |||||||||||||||||||||||||
| Tranche 4 | 559,185\u00a0 | $ | 1.45\u00a0 | $ | 10.00\u00a0 | August 1, 2023 - August 1, 2028 | 2.27 years - 3 years | |||||||||||||||||||||||||
| Tranche 5 | 8,439\u00a0 | $ | 0.98\u00a0 | $ | 2.50\u00a0 | February 1, 2024 - February 1, 2029 | 1.29 years - 3 years | |||||||||||||||||||||||||
| Tranche 6 | 8,437\u00a0 | $ | 0.84\u00a0 | $ | 5.00\u00a0 | February 1, 2024 - February 1, 2029 | 2.20 years - 3 years | |||||||||||||||||||||||||
| Tranche 7 | 8,441\u00a0 | $ | 0.75\u00a0 | $ | 7.50\u00a0 | February 1, 2024 - February 1, 2029 | 2.64 years - 3 years | |||||||||||||||||||||||||
| Tranche 8 | 8,438\u00a0 | $ | 0.67\u00a0 | $ | 10.00\u00a0 | February 1, 2024 - February 1, 2029 | 2.90 years - 3 years |
| Number of Shares per Tranche | Grant Date Fair Value (per Share) | Stock Price Hurdle (per Share) | Performance Period | Requisite Service Period | ||||||||||||||||||||||||||||
| Tranche 1 | 1,055,674\u00a0 | $ | 1.52\u00a0 | $ | 4.00\u00a0 | August 1, 2022 - August 1, 2027 | 1.39 years - 3 years | |||||||||||||||||||||||||
| Tranche 2 | 1,055,648\u00a0 | $ | 1.25\u00a0 | $ | 7.50\u00a0 | August 1, 2022 - August 1, 2027 | 2.33 years - 3 years | |||||||||||||||||||||||||
| Tranche 3 | 1,055,674\u00a0 | $ | 1.11\u00a0 | $ | 10.00\u00a0 | August 1, 2022 - August 1, 2027 | 2.66 years - 3 years | |||||||||||||||||||||||||
| Tranche 4 | 1,055,648\u00a0 | $ | 1.01\u00a0 | $ | 12.50\u00a0 | August 1, 2022 - August 1, 2027 | 2.90 years - 3 years |
PVU\u2019s Granted February 1, 2024 | PVU\u2019s Granted August 1, 2023 | PVU\u2019s Granted August 1, 2022 | ||||||||||||||||||
| Share price as of grant date | $1.11 | $1.38 | $1.80 | |||||||||||||||||
| Volatility | 90.8% | 94.3% | 79.3% | |||||||||||||||||
| Risk-free interest rate | 3.7% | 4.1% | 2.6% | |||||||||||||||||
| Cost of Equity | 11.6% | 9.2% | 10.6% | |||||||||||||||||
| Dividend yield | \u2014% | \u2014% | \u2014% |
| Number of Price-Vested Units | Weighted-Average Grant Date Fair Value | ||||||||||
Unvested as of June\u00a030, 2023 | 4,044,180\u00a0 | $ | 1.22\u00a0 | ||||||||
| Granted | 2,270,530\u00a0 | 1.62 | |||||||||
| Vested | \u2014\u00a0 | \u2014\u00a0 | |||||||||
| Forfeited | (144,325) | 1.36 | |||||||||
Unvested as of June\u00a030, 2024 | 6,170,385\u00a0 | $ | 1.37\u00a0 |
| ESPP | 159\u00a0 | |||||||
| Stock awards outstanding under 2020 Plan | 17,940,564\u00a0 | |||||||
| Stock awards available for grant under 2020 Plan | 4,030,428\u00a0 | |||||||
| Options outstanding under 2003 Plan | 515,692\u00a0 | |||||||
| Total | 22,486,843\u00a0 |
| Year Ended June 30, | ||||||||||||||||||||
| (in thousands) | 2024 | 2023 | 2022 | |||||||||||||||||
| Share-based compensation related to: | ||||||||||||||||||||
| Equity classified stock options | $ | 2,733\u00a0 | $ | 3,249\u00a0 | $ | 3,145\u00a0 | ||||||||||||||
| Equity classified RSU's | 7,701\u00a0 | 5,958\u00a0 | 3,948\u00a0 | |||||||||||||||||
| Equity classified PSU's | 33\u00a0 | 100\u00a0 | (578) | |||||||||||||||||
| Equity classified PVU's | 3,349\u00a0 | 1,876\u00a0 | \u2014\u00a0 | |||||||||||||||||
| Total | $ | 13,816\u00a0 | $ | 11,183\u00a0 | $ | 6,515\u00a0 |
| Year Ended June 30, | |||||||||||
| 2022 | |||||||||||
Volatility | 36.0% | ||||||||||
Risk-free interest rate | 1.4% | ||||||||||
Dividend yield | \u2014% | ||||||||||
Assumed forfeitures | \u2014% | ||||||||||
Expected term (in years) | 6.25 | ||||||||||
Weighted-average fair value (per share) | $3.36 |
PVU\u2019s Granted February 1, 2024 | PVU\u2019s Granted August 1, 2023 | PVU\u2019s Granted August 1, 2022 | ||||||||||||||||||
| Share price as of grant date | $1.11 | $1.38 | $1.80 | |||||||||||||||||
| Volatility | 90.8% | 94.3% | 79.3% | |||||||||||||||||
| Risk-free interest rate | 3.7% | 4.1% | 2.6% | |||||||||||||||||
| Cost of Equity | 11.6% | 9.2% | 10.6% | |||||||||||||||||
| Dividend yield | \u2014% | \u2014% | \u2014% |
| Number of Options | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Term (in Years) | Aggregate Intrinsic Value (in Thousands) | |||||||||||
Outstanding\u2014June\u00a030, 2023 | 3,847,339\u00a0 | $ | 11.56\u00a0 | |||||||||||
| Options granted | \u2014\u00a0 | \u2014\u00a0 | ||||||||||||
| Options exercised | (46,769) | 1.74\u00a0 | ||||||||||||
| Options forfeited/expired/cancelled | (122,606) | 7.99\u00a0 | ||||||||||||
Outstanding\u2014June\u00a030, 2024 | 3,677,964\u00a0 | $ | 11.81\u00a0 | 6.40 | $ | 744\u00a0 | ||||||||
Vested and exercisable\u2014June\u00a030, 2024 | 2,492,868\u00a0 | $ | 11.97\u00a0 | 6.00 | $ | 630\u00a0 |
| Number of Restricted Stock Units | Weighted-Average Grant Date Fair Value | ||||||||||
Unvested as of June\u00a030, 2023 | 4,911,613\u00a0 | $ | 2.57\u00a0 | ||||||||
| Granted | 6,578,688\u00a0 | 1.49\u00a0 | |||||||||
| Vested | (2,664,436) | 2.06\u00a0 | |||||||||
| Forfeited | (384,697) | 2.12\u00a0 | |||||||||
Unvested as of June\u00a030, 2024 | 8,441,168\u00a0 | $ | 1.91\u00a0 |
| Number of Performance Stock Units | Weighted-Average Grant Date Fair Value | ||||||||||
Unvested as of June\u00a030, 2023 | 13,365\u00a0 | $ | 17.96\u00a0 | ||||||||
| Granted | \u2014\u00a0 | \u2014\u00a0 | |||||||||
| Vested | (14,477) | 17.95\u00a0 | |||||||||
| Forfeited | \u2014\u00a0 | \u2014\u00a0 | |||||||||
Performance adjustment(1) | 1,112\u00a0 | \u2014\u00a0 | |||||||||
Unvested as of June\u00a030, 2024 | \u2014\u00a0 | $ | \u2014\u00a0 |
| Number of Shares per Tranche | Grant Date Fair Value (per Share) | Stock Price Hurdle (per Share) | Performance Period | Requisite Service Period | ||||||||||||||||||||||||||||
| Tranche 1 | 559,202\u00a0 | $ | 1.85\u00a0 | $ | 2.50\u00a0 | August 1, 2023 - August 1, 2028 | 1 year - 3 years | |||||||||||||||||||||||||
| Tranche 2 | 559,175\u00a0 | $ | 1.69\u00a0 | $ | 5.00\u00a0 | August 1, 2023 - August 1, 2028 | 1.41 years - 3 years | |||||||||||||||||||||||||
| Tranche 3 | 559,213\u00a0 | $ | 1.55\u00a0 | $ | 7.50\u00a0 | August 1, 2023 - August 1, 2028 | 1.96 years - 3 years | |||||||||||||||||||||||||
| Tranche 4 | 559,185\u00a0 | $ | 1.45\u00a0 | $ | 10.00\u00a0 | August 1, 2023 - August 1, 2028 | 2.27 years - 3 years | |||||||||||||||||||||||||
| Tranche 5 | 8,439\u00a0 | $ | 0.98\u00a0 | $ | 2.50\u00a0 | February 1, 2024 - February 1, 2029 | 1.29 years - 3 years | |||||||||||||||||||||||||
| Tranche 6 | 8,437\u00a0 | $ | 0.84\u00a0 | $ | 5.00\u00a0 | February 1, 2024 - February 1, 2029 | 2.20 years - 3 years | |||||||||||||||||||||||||
| Tranche 7 | 8,441\u00a0 | $ | 0.75\u00a0 | $ | 7.50\u00a0 | February 1, 2024 - February 1, 2029 | 2.64 years - 3 years | |||||||||||||||||||||||||
| Tranche 8 | 8,438\u00a0 | $ | 0.67\u00a0 | $ | 10.00\u00a0 | February 1, 2024 - February 1, 2029 | 2.90 years - 3 years |
| Number of Shares per Tranche | Grant Date Fair Value (per Share) | Stock Price Hurdle (per Share) | Performance Period | Requisite Service Period | ||||||||||||||||||||||||||||
| Tranche 1 | 1,055,674\u00a0 | $ | 1.52\u00a0 | $ | 4.00\u00a0 | August 1, 2022 - August 1, 2027 | 1.39 years - 3 years | |||||||||||||||||||||||||
| Tranche 2 | 1,055,648\u00a0 | $ | 1.25\u00a0 | $ | 7.50\u00a0 | August 1, 2022 - August 1, 2027 | 2.33 years - 3 years | |||||||||||||||||||||||||
| Tranche 3 | 1,055,674\u00a0 | $ | 1.11\u00a0 | $ | 10.00\u00a0 | August 1, 2022 - August 1, 2027 | 2.66 years - 3 years | |||||||||||||||||||||||||
| Tranche 4 | 1,055,648\u00a0 | $ | 1.01\u00a0 | $ | 12.50\u00a0 | August 1, 2022 - August 1, 2027 | 2.90 years - 3 years |
| Number of Price-Vested Units | Weighted-Average Grant Date Fair Value | ||||||||||
Unvested as of June\u00a030, 2023 | 4,044,180\u00a0 | $ | 1.22\u00a0 | ||||||||
| Granted | 2,270,530\u00a0 | 1.62 | |||||||||
| Vested | \u2014\u00a0 | \u2014\u00a0 | |||||||||
| Forfeited | (144,325) | 1.36 | |||||||||
Unvested as of June\u00a030, 2024 | 6,170,385\u00a0 | $ | 1.37\u00a0 |
| Year Ended June 30, | ||||||||||||||||||||
| (in thousands) | 2024 | 2023 | 2022 | |||||||||||||||||
| Senior: | ||||||||||||||||||||
Medicare advantage commissions | $ | 569,648\u00a0 | $ | 500,501\u00a0 | $ | 409,090\u00a0 | ||||||||||||||
Medicare supplement commissions | 3,026\u00a0 | 1,668\u00a0 | 5,224\u00a0 | |||||||||||||||||
Prescription drug plan commissions | 1,485\u00a0 | 513\u00a0 | (170) | |||||||||||||||||
Dental, vision, and health commissions | 4,252\u00a0 | 3,855\u00a0 | 15,056\u00a0 | |||||||||||||||||
Other commissions | 2,474\u00a0 | 2,697\u00a0 | 7,824\u00a0 | |||||||||||||||||
Other services | 74,964\u00a0 | 80,897\u00a0 | 90,883\u00a0 | |||||||||||||||||
| Total Senior revenue | 655,849\u00a0 | 590,131\u00a0 | 527,907\u00a0 | |||||||||||||||||
| Healthcare Services: | ||||||||||||||||||||
Pharmacy | 464,853\u00a0 | 239,547\u00a0 | 59,460\u00a0 | |||||||||||||||||
Other services | 13,655\u00a0 | 12,528\u00a0 | 10,575\u00a0 | |||||||||||||||||
| Total Healthcare Services revenue | 478,508\u00a0 | 252,075\u00a0 | 70,035\u00a0 | |||||||||||||||||
| Life: | ||||||||||||||||||||
Term commissions | 73,980\u00a0 | 70,094\u00a0 | 65,539\u00a0 | |||||||||||||||||
Final expense commissions | 64,138\u00a0 | 56,488\u00a0 | 68,295\u00a0 | |||||||||||||||||
Other services | 19,812\u00a0 | 19,250\u00a0 | 20,139\u00a0 | |||||||||||||||||
| Total Life revenue | 157,930\u00a0 | 145,832\u00a0 | 153,973\u00a0 | |||||||||||||||||
| Auto & Home: | ||||||||||||||||||||
Commissions | 35,244\u00a0 | 20,450\u00a0 | 25,851\u00a0 | |||||||||||||||||
Other services | 984\u00a0 | 1,412\u00a0 | 2,030\u00a0 | |||||||||||||||||
| Total Auto & Home revenue | 36,228\u00a0 | 21,862\u00a0 | 27,881\u00a0 | |||||||||||||||||
| Eliminations: | ||||||||||||||||||||
Commissions | (2,567) | (2,796) | (9,191) | |||||||||||||||||
Other services | (4,172) | (4,256) | (6,560) | |||||||||||||||||
| Total Elimination revenue | (6,739) | (7,052) | (15,751) | |||||||||||||||||
Total Commissions and other services revenue | 856,923\u00a0 | 763,301\u00a0 | 704,585\u00a0 | |||||||||||||||||
Total Pharmacy revenue | 464,853\u00a0 | 239,547\u00a0 | 59,460\u00a0 | |||||||||||||||||
Total Revenue | $ | 1,321,776\u00a0 | $ | 1,002,848\u00a0 | $ | 764,045\u00a0 |
| (in thousands) | ||||||||
Balance as of June\u00a030, 2022 | $ | 838,626\u00a0 | ||||||
Commission revenue from revenue recognized | 259,933\u00a0 | |||||||
| Net commission revenue adjustment from change in estimate | (7,442) | |||||||
Change in estimate from mutual contract termination | (10,427) | |||||||
| Amounts recognized as accounts receivable, net | (240,192) | |||||||
Balance as of June\u00a030, 2023 | 840,498\u00a0 | |||||||
Commission revenue from revenue recognized | 279,575\u00a0 | |||||||
| Net commission revenue adjustment from change in estimate | 3,436\u00a0 | |||||||
| Amounts recognized as accounts receivable, net | (242,192) | |||||||
Balance as of June\u00a030, 2024 | $ | 881,317\u00a0 |
Balance as of June\u00a030, 2022 | $ | 3,404\u00a0 | ||||||
Commission and other services revenue recognized | (76,039) | |||||||
| Amounts recognized as contract liabilities | 74,326\u00a0 | |||||||
Balance as of June\u00a030, 2023 | $ | 1,691\u00a0 | ||||||
Commission and other services revenue recognized | (30,927) | |||||||
| Amounts recognized as contract liabilities | 37,302\u00a0 | |||||||
Balance as of June\u00a030, 2024 | $ | 8,066\u00a0 |
| Year Ended June 30, | ||||||||||||||||||||
| (in thousands) | 2024 | 2023 | 2022 | |||||||||||||||||
| Senior: | ||||||||||||||||||||
Medicare advantage commissions | $ | 569,648\u00a0 | $ | 500,501\u00a0 | $ | 409,090\u00a0 | ||||||||||||||
Medicare supplement commissions | 3,026\u00a0 | 1,668\u00a0 | 5,224\u00a0 | |||||||||||||||||
Prescription drug plan commissions | 1,485\u00a0 | 513\u00a0 | (170) | |||||||||||||||||
Dental, vision, and health commissions | 4,252\u00a0 | 3,855\u00a0 | 15,056\u00a0 | |||||||||||||||||
Other commissions | 2,474\u00a0 | 2,697\u00a0 | 7,824\u00a0 | |||||||||||||||||
Other services | 74,964\u00a0 | 80,897\u00a0 | 90,883\u00a0 | |||||||||||||||||
| Total Senior revenue | 655,849\u00a0 | 590,131\u00a0 | 527,907\u00a0 | |||||||||||||||||
| Healthcare Services: | ||||||||||||||||||||
Pharmacy | 464,853\u00a0 | 239,547\u00a0 | 59,460\u00a0 | |||||||||||||||||
Other services | 13,655\u00a0 | 12,528\u00a0 | 10,575\u00a0 | |||||||||||||||||
| Total Healthcare Services revenue | 478,508\u00a0 | 252,075\u00a0 | 70,035\u00a0 | |||||||||||||||||
| Life: | ||||||||||||||||||||
Term commissions | 73,980\u00a0 | 70,094\u00a0 | 65,539\u00a0 | |||||||||||||||||
Final expense commissions | 64,138\u00a0 | 56,488\u00a0 | 68,295\u00a0 | |||||||||||||||||
Other services | 19,812\u00a0 | 19,250\u00a0 | 20,139\u00a0 | |||||||||||||||||
| Total Life revenue | 157,930\u00a0 | 145,832\u00a0 | 153,973\u00a0 | |||||||||||||||||
| Auto & Home: | ||||||||||||||||||||
Commissions | 35,244\u00a0 | 20,450\u00a0 | 25,851\u00a0 | |||||||||||||||||
Other services | 984\u00a0 | 1,412\u00a0 | 2,030\u00a0 | |||||||||||||||||
| Total Auto & Home revenue | 36,228\u00a0 | 21,862\u00a0 | 27,881\u00a0 | |||||||||||||||||
| Eliminations: | ||||||||||||||||||||
Commissions | (2,567) | (2,796) | (9,191) | |||||||||||||||||
Other services | (4,172) | (4,256) | (6,560) | |||||||||||||||||
| Total Elimination revenue | (6,739) | (7,052) | (15,751) | |||||||||||||||||
Total Commissions and other services revenue | 856,923\u00a0 | 763,301\u00a0 | 704,585\u00a0 | |||||||||||||||||
Total Pharmacy revenue | 464,853\u00a0 | 239,547\u00a0 | 59,460\u00a0 | |||||||||||||||||
Total Revenue | $ | 1,321,776\u00a0 | $ | 1,002,848\u00a0 | $ | 764,045\u00a0 |
| (in thousands) | ||||||||
Balance as of June\u00a030, 2022 | $ | 838,626\u00a0 | ||||||
Commission revenue from revenue recognized | 259,933\u00a0 | |||||||
| Net commission revenue adjustment from change in estimate | (7,442) | |||||||
Change in estimate from mutual contract termination | (10,427) | |||||||
| Amounts recognized as accounts receivable, net | (240,192) | |||||||
Balance as of June\u00a030, 2023 | 840,498\u00a0 | |||||||
Commission revenue from revenue recognized | 279,575\u00a0 | |||||||
| Net commission revenue adjustment from change in estimate | 3,436\u00a0 | |||||||
| Amounts recognized as accounts receivable, net | (242,192) | |||||||
Balance as of June\u00a030, 2024 | $ | 881,317\u00a0 |
Balance as of June\u00a030, 2022 | $ | 3,404\u00a0 | ||||||
Commission and other services revenue recognized | (76,039) | |||||||
| Amounts recognized as contract liabilities | 74,326\u00a0 | |||||||
Balance as of June\u00a030, 2023 | $ | 1,691\u00a0 | ||||||
Commission and other services revenue recognized | (30,927) | |||||||
| Amounts recognized as contract liabilities | 37,302\u00a0 | |||||||
Balance as of June\u00a030, 2024 | $ | 8,066\u00a0 |
| Year Ended June 30, | |||||||||||||||||
| (in thousands) | 2024 | 2023 | 2022 | ||||||||||||||
| Current income taxes: | |||||||||||||||||
| Federal | $ | 2,523\u00a0 | $ | 102\u00a0 | $ | \u2014\u00a0 | |||||||||||
| State | 1,286\u00a0 | 544\u00a0 | 479\u00a0 | ||||||||||||||
| Total | 3,809\u00a0 | 646\u00a0 | 479\u00a0 | ||||||||||||||
| Deferred income taxes: | |||||||||||||||||
| Federal | (2,805) | (12,365) | (77,242) | ||||||||||||||
| State | 4,055\u00a0 | 1,119\u00a0 | (15,539) | ||||||||||||||
| Total | 1,250\u00a0 | (11,246) | (92,781) | ||||||||||||||
Income tax expense (benefit) | $ | 5,059\u00a0 | $ | (10,600) | $ | (92,302) |
| Year Ended June 30, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Federal statutory rate | 21.0% | 21.0% | 21.0% | ||||||||||||||
Differences in income tax expense resulting from: | |||||||||||||||||
| State income taxes | 5.9 | 3.1 | 5.0 | ||||||||||||||
| Executive officer compensation | (0.4) | (1.1) | \u2014 | ||||||||||||||
| Equity compensation | (0.7) | (1.1) | \u2014 | ||||||||||||||
| Change in valuation allowance | (37.0) | (5.4) | \u2014 | ||||||||||||||
| Change in state tax rate | 12.1 | \u2014 | (1.9) | ||||||||||||||
| Deferred adjustments | (0.8) | (1.1) | \u2014 | ||||||||||||||
Deferred revaluation | (17.6) | \u2014 | \u2014 | ||||||||||||||
| Other | 0.1 | (0.1) | (0.4) | ||||||||||||||
| Effective income tax rate | (17.4)% | 15.3% | 23.7% |
| (in thousands) | 2024 | 2023 | |||||||||
| Deferred tax assets: | |||||||||||
| \u00a0\u00a0Accruals and other | $ | 23,498\u00a0 | $ | 17,299\u00a0 | |||||||
| Lease liability | 7,994\u00a0 | 8,543\u00a0 | |||||||||
| \u00a0\u00a0Interest expense limitation | 56,309\u00a0 | 43,479\u00a0 | |||||||||
| \u00a0\u00a0Net operating losses | 149,780\u00a0 | 153,930\u00a0 | |||||||||
| \u00a0\u00a0Credit carryforward | 4,393\u00a0 | 4,733\u00a0 | |||||||||
| Basis difference in fixed and amortizable assets | 11,310\u00a0 | 8,183\u00a0 | |||||||||
| Total deferred tax assets | 253,284\u00a0 | 236,167\u00a0 | |||||||||
Less: Valuation allowance | (14,476) | (3,716) | |||||||||
Deferred tax assets, net of valuation allowance | 238,808\u00a0 | 232,451\u00a0 | |||||||||
| Deferred tax liabilities: | |||||||||||
| \u00a0\u00a0Commissions receivable | (268,656) | (261,207) | |||||||||
| Lease right-of-use asset | (6,175) | (6,103) | |||||||||
| Interest rate swap | (1,455) | (4,722) | |||||||||
\u00a0\u00a0Total deferred tax liabilities | (276,286) | (272,032) | |||||||||
| Net long-term deferred tax liabilities | $ | (37,478) | $ | (39,581) |
| Year Ended June 30, | |||||||||||||||||
| (in thousands) | 2024 | 2023 | 2022 | ||||||||||||||
| Current income taxes: | |||||||||||||||||
| Federal | $ | 2,523\u00a0 | $ | 102\u00a0 | $ | \u2014\u00a0 | |||||||||||
| State | 1,286\u00a0 | 544\u00a0 | 479\u00a0 | ||||||||||||||
| Total | 3,809\u00a0 | 646\u00a0 | 479\u00a0 | ||||||||||||||
| Deferred income taxes: | |||||||||||||||||
| Federal | (2,805) | (12,365) | (77,242) | ||||||||||||||
| State | 4,055\u00a0 | 1,119\u00a0 | (15,539) | ||||||||||||||
| Total | 1,250\u00a0 | (11,246) | (92,781) | ||||||||||||||
Income tax expense (benefit) | $ | 5,059\u00a0 | $ | (10,600) | $ | (92,302) |
| Year Ended June 30, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Federal statutory rate | 21.0% | 21.0% | 21.0% | ||||||||||||||
Differences in income tax expense resulting from: | |||||||||||||||||
| State income taxes | 5.9 | 3.1 | 5.0 | ||||||||||||||
| Executive officer compensation | (0.4) | (1.1) | \u2014 | ||||||||||||||
| Equity compensation | (0.7) | (1.1) | \u2014 | ||||||||||||||
| Change in valuation allowance | (37.0) | (5.4) | \u2014 | ||||||||||||||
| Change in state tax rate | 12.1 | \u2014 | (1.9) | ||||||||||||||
| Deferred adjustments | (0.8) | (1.1) | \u2014 | ||||||||||||||
Deferred revaluation | (17.6) | \u2014 | \u2014 | ||||||||||||||
| Other | 0.1 | (0.1) | (0.4) | ||||||||||||||
| Effective income tax rate | (17.4)% | 15.3% | 23.7% |
| (in thousands) | 2024 | 2023 | |||||||||
| Deferred tax assets: | |||||||||||
| \u00a0\u00a0Accruals and other | $ | 23,498\u00a0 | $ | 17,299\u00a0 | |||||||
| Lease liability | 7,994\u00a0 | 8,543\u00a0 | |||||||||
| \u00a0\u00a0Interest expense limitation | 56,309\u00a0 | 43,479\u00a0 | |||||||||
| \u00a0\u00a0Net operating losses | 149,780\u00a0 | 153,930\u00a0 | |||||||||
| \u00a0\u00a0Credit carryforward | 4,393\u00a0 | 4,733\u00a0 | |||||||||
| Basis difference in fixed and amortizable assets | 11,310\u00a0 | 8,183\u00a0 | |||||||||
| Total deferred tax assets | 253,284\u00a0 | 236,167\u00a0 | |||||||||
Less: Valuation allowance | (14,476) | (3,716) | |||||||||
Deferred tax assets, net of valuation allowance | 238,808\u00a0 | 232,451\u00a0 | |||||||||
| Deferred tax liabilities: | |||||||||||
| \u00a0\u00a0Commissions receivable | (268,656) | (261,207) | |||||||||
| Lease right-of-use asset | (6,175) | (6,103) | |||||||||
| Interest rate swap | (1,455) | (4,722) | |||||||||
\u00a0\u00a0Total deferred tax liabilities | (276,286) | (272,032) | |||||||||
| Net long-term deferred tax liabilities | $ | (37,478) | $ | (39,581) |
| Year Ended June 30, | |||||||||||||||||
(in thousands, except per share amounts) | 2024 | 2023 | 2022 | ||||||||||||||
| Basic: | |||||||||||||||||
| Numerator: | |||||||||||||||||
Net loss attributable to common shareholders | $ | (34,125) | $ | (58,544) | $ | (297,504) | |||||||||||
| Denominator: | |||||||||||||||||
| Weighted-average common stock outstanding | 168,519\u00a0 | 166,140\u00a0 | 164,042\u00a0 | ||||||||||||||
Net loss per share\u2014basic: | $ | (0.20) | $ | (0.35) | $ | (1.81) | |||||||||||
| Diluted: | |||||||||||||||||
| Numerator: | |||||||||||||||||
Net loss attributable to common and common equivalent shareholders | $ | (34,125) | $ | (58,544) | $ | (297,504) | |||||||||||
| Denominator: | |||||||||||||||||
| Weighted-average common stock outstanding | 168,519\u00a0 | 166,140\u00a0 | 164,042\u00a0 | ||||||||||||||
Stock options outstanding to purchase shares of common stock including unvested RSU's and from the ESPP(1) | \u2014\u00a0 | \u2014\u00a0 | \u2014\u00a0 | ||||||||||||||
| Total common and common equivalent shares outstanding | 168,519\u00a0 | 166,140\u00a0 | 164,042\u00a0 | ||||||||||||||
Net loss per share\u2014diluted: | $ | (0.20) | $ | (0.35) | $ | (1.81) |
| (in thousands) | 2024 | 2023 | 2022 | ||||||||||||||
| Stock options outstanding to purchase shares of common stock including unvested RSU's and from the ESPP | 12,204\u00a0 | 8,456\u00a0 | 5,382\u00a0 |
| (in thousands) | 2024 | 2023 | 2022 | ||||||||||||||
| Shares subject to outstanding PVU\u2019s | 6,243\u00a0 | 4,346\u00a0 | \u2014\u00a0 | ||||||||||||||
| Shares subject to outstanding PSU's | \u2014\u00a0 | 9\u00a0 | 168\u00a0 | ||||||||||||||
| Total | 6,243\u00a0 | 4,355\u00a0 | 168\u00a0 |
| Year Ended June 30, | |||||||||||||||||
(in thousands, except per share amounts) | 2024 | 2023 | 2022 | ||||||||||||||
| Basic: | |||||||||||||||||
| Numerator: | |||||||||||||||||
Net loss attributable to common shareholders | $ | (34,125) | $ | (58,544) | $ | (297,504) | |||||||||||
| Denominator: | |||||||||||||||||
| Weighted-average common stock outstanding | 168,519\u00a0 | 166,140\u00a0 | 164,042\u00a0 | ||||||||||||||
Net loss per share\u2014basic: | $ | (0.20) | $ | (0.35) | $ | (1.81) | |||||||||||
| Diluted: | |||||||||||||||||
| Numerator: | |||||||||||||||||
Net loss attributable to common and common equivalent shareholders | $ | (34,125) | $ | (58,544) | $ | (297,504) | |||||||||||
| Denominator: | |||||||||||||||||
| Weighted-average common stock outstanding | 168,519\u00a0 | 166,140\u00a0 | 164,042\u00a0 | ||||||||||||||
Stock options outstanding to purchase shares of common stock including unvested RSU's and from the ESPP(1) | \u2014\u00a0 | \u2014\u00a0 | \u2014\u00a0 | ||||||||||||||
| Total common and common equivalent shares outstanding | 168,519\u00a0 | 166,140\u00a0 | 164,042\u00a0 | ||||||||||||||
Net loss per share\u2014diluted: | $ | (0.20) | $ | (0.35) | $ | (1.81) |
| (in thousands) | 2024 | 2023 | 2022 | ||||||||||||||
| Stock options outstanding to purchase shares of common stock including unvested RSU's and from the ESPP | 12,204\u00a0 | 8,456\u00a0 | 5,382\u00a0 |
| (in thousands) | 2024 | 2023 | 2022 | ||||||||||||||
| Shares subject to outstanding PVU\u2019s | 6,243\u00a0 | 4,346\u00a0 | \u2014\u00a0 | ||||||||||||||
| Shares subject to outstanding PSU's | \u2014\u00a0 | 9\u00a0 | 168\u00a0 | ||||||||||||||
| Total | 6,243\u00a0 | 4,355\u00a0 | 168\u00a0 |
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Elims | Consolidated | |||||||||||||||||||||||||||||
External revenue | $ | 649,232\u00a0 | $ | 478,491\u00a0 | $ | 157,826\u00a0 | $ | 36,227\u00a0 | $ | \u2014\u00a0 | $ | 1,321,776\u00a0 | |||||||||||||||||||||||
Intersegment revenue | 6,617\u00a0 | 17\u00a0 | 104\u00a0 | 1\u00a0 | (6,739) | \u2014\u00a0 | |||||||||||||||||||||||||||||
Total revenue | $ | 655,849\u00a0 | $ | 478,508\u00a0 | $ | 157,930\u00a0 | $ | 36,228\u00a0 | $ | (6,739) | $ | 1,321,776\u00a0 |
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Total | ||||||||||||||||||||||||
Adjusted Segment EBITDA | $ | 166,744\u00a0 | $ | 7,821\u00a0 | $ | 20,164\u00a0 | $ | 14,127\u00a0 | $ | 208,856\u00a0 | |||||||||||||||||||
Corporate & elimination of intersegment profits | (91,863) | ||||||||||||||||||||||||||||
| Share-based compensation expense | (13,816) | ||||||||||||||||||||||||||||
Transaction costs (1) | (13,158) | ||||||||||||||||||||||||||||
| Depreciation and amortization | (24,998) | ||||||||||||||||||||||||||||
| Loss on disposal of property, equipment, and software, net | (536) | ||||||||||||||||||||||||||||
| Interest expense, net | (93,551) | ||||||||||||||||||||||||||||
Loss before income tax expense (benefit) | $ | (29,066) | |||||||||||||||||||||||||||
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Elims | Consolidated | |||||||||||||||||||||||||||||
External revenue | $ | 583,271\u00a0 | $ | 252,075\u00a0 | $ | 145,640\u00a0 | $ | 21,862\u00a0 | $ | \u2014\u00a0 | $ | 1,002,848\u00a0 | |||||||||||||||||||||||
Intersegment revenue | 6,860\u00a0 | \u2014\u00a0 | 192\u00a0 | \u2014\u00a0 | (7,052) | \u2014\u00a0 | |||||||||||||||||||||||||||||
Total revenue | $ | 590,131\u00a0 | $ | 252,075\u00a0 | $ | 145,832\u00a0 | $ | 21,862\u00a0 | $ | (7,052) | $ | 1,002,848\u00a0 | |||||||||||||||||||||||
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Total | ||||||||||||||||||||||||
Adjusted Segment EBITDA | $ | 155,077\u00a0 | $ | (22,769) | $ | 23,073\u00a0 | $ | 81\u00a0 | $ | 155,462\u00a0 | |||||||||||||||||||
Corporate & elimination of intersegment profits | (81,159) | ||||||||||||||||||||||||||||
| Share-based compensation expense | (11,310) | ||||||||||||||||||||||||||||
Transaction costs (1) | (5,569) | ||||||||||||||||||||||||||||
| Depreciation and amortization | (27,881) | ||||||||||||||||||||||||||||
Loss on disposal of property, equipment, and software, net | (749) | ||||||||||||||||||||||||||||
| Impairment of long-lived assets | (17,332) | ||||||||||||||||||||||||||||
| Interest expense, net | (80,606) | ||||||||||||||||||||||||||||
Loss before income tax expense (benefit) | $ | (69,144) | |||||||||||||||||||||||||||
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Elims | Consolidated | |||||||||||||||||||||||||||||
External revenue | $ | 514,429\u00a0 | $ | 70,035\u00a0 | $ | 151,704\u00a0 | $ | 27,877\u00a0 | $ | \u2014\u00a0 | $ | 764,045\u00a0 | |||||||||||||||||||||||
Intersegment revenue | 13,478\u00a0 | \u2014\u00a0 | 2,269\u00a0 | 4\u00a0 | (15,751) | \u2014\u00a0 | |||||||||||||||||||||||||||||
Total revenue | $ | 527,907\u00a0 | $ | 70,035\u00a0 | $ | 153,973\u00a0 | $ | 27,881\u00a0 | $ | (15,751) | $ | 764,045\u00a0 | |||||||||||||||||||||||
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Total | ||||||||||||||||||||||||
Adjusted Segment EBITDA | $ | (161,702) | $ | (32,097) | $ | (129) | $ | 5,433\u00a0 | $ | (188,495) | |||||||||||||||||||
Corporate & elimination of intersegment profits | (72,011) | ||||||||||||||||||||||||||||
| Share-based compensation expense | (7,052) | ||||||||||||||||||||||||||||
Non-recurring expenses (1) | (4,730) | ||||||||||||||||||||||||||||
| Depreciation and amortization | (24,724) | ||||||||||||||||||||||||||||
| Loss on disposal of property, equipment and software | (1,456) | ||||||||||||||||||||||||||||
Goodwill impairment | (44,596) | ||||||||||||||||||||||||||||
| Impairment of long-lived assets | (3,147) | ||||||||||||||||||||||||||||
| Interest expense, net | (43,595) | ||||||||||||||||||||||||||||
Loss before income tax expense (benefit) | $ | (389,806) | |||||||||||||||||||||||||||
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Elims | Consolidated | |||||||||||||||||||||||||||||
External revenue | $ | 649,232\u00a0 | $ | 478,491\u00a0 | $ | 157,826\u00a0 | $ | 36,227\u00a0 | $ | \u2014\u00a0 | $ | 1,321,776\u00a0 | |||||||||||||||||||||||
Intersegment revenue | 6,617\u00a0 | 17\u00a0 | 104\u00a0 | 1\u00a0 | (6,739) | \u2014\u00a0 | |||||||||||||||||||||||||||||
Total revenue | $ | 655,849\u00a0 | $ | 478,508\u00a0 | $ | 157,930\u00a0 | $ | 36,228\u00a0 | $ | (6,739) | $ | 1,321,776\u00a0 |
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Total | ||||||||||||||||||||||||
Adjusted Segment EBITDA | $ | 166,744\u00a0 | $ | 7,821\u00a0 | $ | 20,164\u00a0 | $ | 14,127\u00a0 | $ | 208,856\u00a0 | |||||||||||||||||||
Corporate & elimination of intersegment profits | (91,863) | ||||||||||||||||||||||||||||
| Share-based compensation expense | (13,816) | ||||||||||||||||||||||||||||
Transaction costs (1) | (13,158) | ||||||||||||||||||||||||||||
| Depreciation and amortization | (24,998) | ||||||||||||||||||||||||||||
| Loss on disposal of property, equipment, and software, net | (536) | ||||||||||||||||||||||||||||
| Interest expense, net | (93,551) | ||||||||||||||||||||||||||||
Loss before income tax expense (benefit) | $ | (29,066) | |||||||||||||||||||||||||||
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Elims | Consolidated | |||||||||||||||||||||||||||||
External revenue | $ | 583,271\u00a0 | $ | 252,075\u00a0 | $ | 145,640\u00a0 | $ | 21,862\u00a0 | $ | \u2014\u00a0 | $ | 1,002,848\u00a0 | |||||||||||||||||||||||
Intersegment revenue | 6,860\u00a0 | \u2014\u00a0 | 192\u00a0 | \u2014\u00a0 | (7,052) | \u2014\u00a0 | |||||||||||||||||||||||||||||
Total revenue | $ | 590,131\u00a0 | $ | 252,075\u00a0 | $ | 145,832\u00a0 | $ | 21,862\u00a0 | $ | (7,052) | $ | 1,002,848\u00a0 | |||||||||||||||||||||||
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Total | ||||||||||||||||||||||||
Adjusted Segment EBITDA | $ | 155,077\u00a0 | $ | (22,769) | $ | 23,073\u00a0 | $ | 81\u00a0 | $ | 155,462\u00a0 | |||||||||||||||||||
Corporate & elimination of intersegment profits | (81,159) | ||||||||||||||||||||||||||||
| Share-based compensation expense | (11,310) | ||||||||||||||||||||||||||||
Transaction costs (1) | (5,569) | ||||||||||||||||||||||||||||
| Depreciation and amortization | (27,881) | ||||||||||||||||||||||||||||
Loss on disposal of property, equipment, and software, net | (749) | ||||||||||||||||||||||||||||
| Impairment of long-lived assets | (17,332) | ||||||||||||||||||||||||||||
| Interest expense, net | (80,606) | ||||||||||||||||||||||||||||
Loss before income tax expense (benefit) | $ | (69,144) | |||||||||||||||||||||||||||
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Elims | Consolidated | |||||||||||||||||||||||||||||
External revenue | $ | 514,429\u00a0 | $ | 70,035\u00a0 | $ | 151,704\u00a0 | $ | 27,877\u00a0 | $ | \u2014\u00a0 | $ | 764,045\u00a0 | |||||||||||||||||||||||
Intersegment revenue | 13,478\u00a0 | \u2014\u00a0 | 2,269\u00a0 | 4\u00a0 | (15,751) | \u2014\u00a0 | |||||||||||||||||||||||||||||
Total revenue | $ | 527,907\u00a0 | $ | 70,035\u00a0 | $ | 153,973\u00a0 | $ | 27,881\u00a0 | $ | (15,751) | $ | 764,045\u00a0 | |||||||||||||||||||||||
| (in thousands) | Senior | Healthcare Services | Life | Auto & Home | Total | ||||||||||||||||||||||||
Adjusted Segment EBITDA | $ | (161,702) | $ | (32,097) | $ | (129) | $ | 5,433\u00a0 | $ | (188,495) | |||||||||||||||||||
Corporate & elimination of intersegment profits | (72,011) | ||||||||||||||||||||||||||||
| Share-based compensation expense | (7,052) | ||||||||||||||||||||||||||||
Non-recurring expenses (1) | (4,730) | ||||||||||||||||||||||||||||
| Depreciation and amortization | (24,724) | ||||||||||||||||||||||||||||
| Loss on disposal of property, equipment and software | (1,456) | ||||||||||||||||||||||||||||
Goodwill impairment | (44,596) | ||||||||||||||||||||||||||||
| Impairment of long-lived assets | (3,147) | ||||||||||||||||||||||||||||
| Interest expense, net | (43,595) | ||||||||||||||||||||||||||||
Loss before income tax expense (benefit) | $ | (389,806) | |||||||||||||||||||||||||||